Eli Lilly and Company News Headlines

LLY 
$72.45
*  
2.17
3.09%
Get LLY Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Celgene: Was Abraxis Worth It?
10/15/2012 4:55:00 PM - Seeking Alpha


Pfizer: Big Pharma's Biggest Value
10/15/2012 12:38:00 PM - Seeking Alpha


5 Top Pharmaceuticals Paying Substantial Dividends
10/14/2012 6:22:00 AM - Seeking Alpha


Biotech Weekend Recap: Clinical Trials, Company Files
10/14/2012 5:30:00 AM - Seeking Alpha


With Share Offering Registration And Trial Enrollment Complete, Time To Buy MannKind
10/12/2012 5:43:00 PM - Seeking Alpha


Another Prospective Alzheimer's Trial
10/12/2012 2:16:00 PM - Seeking Alpha


Impending Patent Losses Creating Eli Lilly Uncertainty
10/11/2012 12:08:00 PM - Seeking Alpha


Today's Market News To Trade On: 5 Stocks Moving On News
10/10/2012 8:24:00 AM - Seeking Alpha


5 Biotech Companies With Major Market-Moving Announcements To Start The Week
10/10/2012 4:54:00 AM - Seeking Alpha


Today's Market News To Trade On: 5 Stocks Moving On News
10/9/2012 8:01:00 AM - Seeking Alpha


Is Lilly's Solanezumab Worth $3 Billion More?
10/9/2012 4:29:00 AM - Seeking Alpha


Eli Lilly And The State Of The Insulin Battle
10/8/2012 1:18:00 PM - Seeking Alpha


GlaxoSmithKline: Buy For 4.5% Yield
10/8/2012 10:03:00 AM - Seeking Alpha


Vorapaxar For Patients With Previous MI And Merck's Bottom Line
10/5/2012 4:54:00 PM - Seeking Alpha


Magic Formula Dividends For October
10/4/2012 6:35:00 PM - Seeking Alpha


Celgene's Pipeline Offers Catalysts Into 2013
10/3/2012 6:33:00 PM - Seeking Alpha


Sell AstraZeneca: Share Buyback Suspension Comes As Further Bad News
10/3/2012 2:22:00 PM - Seeking Alpha


Good Dividend Payer Merck Has A Pipeline Full Of New Revenue Possibilities
10/3/2012 9:52:00 AM - Seeking Alpha


Credit Suisse Upgrades Pharmaceutical Sector: 3 Stocks To Buy, 1 To Avoid
10/3/2012 2:40:00 AM - Seeking Alpha


Dividend Plays In Big Pharma
10/2/2012 1:38:00 PM - Seeking Alpha


Is Moody's Late To The Drug Party?
10/1/2012 2:49:00 PM - Seeking Alpha


Eli Lilly: Buy Before Sola Approval
10/1/2012 11:35:00 AM - Seeking Alpha


Amarin - A Likely Buyout Candidate For 2012 - Focusing On The Bigger Picture
9/27/2012 10:33:00 AM - Seeking Alpha


Medtronic: Alzheimer's Pump Technology Could Drive Shares Higher Into 2014
9/26/2012 10:33:00 AM - Seeking Alpha


2.4% Yield And 10+ Potential Blockbuster Drugs
9/26/2012 10:05:00 AM - Seeking Alpha